FURUSAKO Shoji | Mochida Pharmaceutical Co., Ltd., Discovery Biology Research of Pharmaceutical Research Center

スポンサーリンク

概要

関連著者

Suzuki Yasushi
Department Of Cardiology Aichi Medical University
Sato Nobuhiro
Department Of Critical Care Medicine Iwate Medical University
Shioya Nobuki
Department Of Critical Care Medicine Iwate Medical University
Endo Shigeatsu
Department Of Critical Care Medicine School Of Medicine Iwate Medical University
Endo Shigeatsu
Department Of Critical Care Medicine Iwate Medical University
Takahashi Gaku
Department Of Critical Care Medicine Iwate Medical University
Yaegashi Yasunori
Department Of Critical Care Medicine Iwate Medical University School Of Medicine
Kojika Masahiro
Department Of Critical Care Medicine Iwate Medical University School Of Medicine
Takahashi Gaku
岩手医科大学医学部救急医学
SHIRAKAWA Kamon
Mochida Pharmaceutical Co., Ltd., Discovery Biology Research of Pharmaceutical Research Center
IMAI Satoko
Department of Critical Care Medicine, Iwate Medical University
MIYATA Michiko
Department of Critical Care Medicine, Iwate Medical University
FURUSAKO Shoji
Mochida Pharmaceutical Co., Ltd., Discovery Biology Research of Pharmaceutical Research Center
Suzuki Yasushi
Department Of Critical Care Medicine Iwate Medical University School Of Medicine
Suzuki Yasushi
Department Of Applied Chemistry School Of Engineering Tokai University
Shirakawa Kamon
Mochida Pharmaceutical Co. Ltd. Discovery Biology Research Of Pharmaceutical Research Center
Furusako Shoji
Mochida Pharmaceutical Co. Ltd. Discovery Biology Research Of Pharmaceutical Research Center
Miyata Michiko
Department Of Critical Care Medicine Iwate Medical University
Imai Satoko
Department Of Critical Care Medicine Iwate Medical University
Suzuki Yasushi
Department Of Agricultural Chemistry The University Of Tokyo
Sato Nobuhiro
Department of Cardio-angiology, Kitasato University School of Medicine

もっと見る

著作論文

Evaluation of a newly identified soluble CD14 subtype as a marker for sepsis

スポンサーリンク